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ABSTRACT
CORRELATIONAL STUDY FOR PREDICTOR VARIABLES AFFECTING
DURATION ON BUBBLE CPAP
By
Alison L. Stoeri, BS, RRT-NPS
Bubble CPAP (BCPAP) is used in the neonatal intensive care unit (NICU) as a form of
non-invasive ventilation and is commonly employed in neonates demonstrating
respiratory distress. BCPAP may be used to avoid the need for intubation and
mechanical ventilation thereby reducing lung injury and other morbidities as well as
decrease hospital stay. PURPOSE: The purpose of this study is to retrospectively
investigate the length of stay on bubble CPAP (BCPAP) considering gestational age,
birth weight, and surfactant delivery in the neonatal population born at an urban tertiary
high load level three (NICU). METHODS: A retrospective study using existing data
from an urban tertiary high load level three NICU was completed. DATA ANALYSIS:
Data analysis was performed using SPSS 16.0. Descriptive statistics were run for each
variable. Contingency tables were run to determine if gestational age at birth, birth
weight, and length of time on BCPAP had significance compared to surfactant delivery.
Intercorrelations were run to determine if gestational age at birth, birth weight, and length
of time on BCPAP had an effect on each other. Davis conventions were used to analyze
the results. RESULTS: Descriptive statistics indicated the mean gestational age at birth
to be 32.263 weeks, SD = +2.978, mean neonatal weight to be 1.899 kg, SD = +0.728,
and mean length of time on BCPAP to be 124.430 hours, SD = +185.474. Contingency
statistics showed a substantial association (reta = 0.562) between the gestational age at
birth and surfactant delivery, a very strong association (reta = 1.000) between the birth
weight and surfactant delivery, and a very strong association (reta = 0.914) between the
length of time the neonate was on BCPAP and surfactant delivery. Pearson productmoment correlation coefficients showed gestational age at birth had a very strong positive
association with birth weight (r = 0.811, p < 0.01) and a moderate negative association
with length of time on BCPAP (r = -0.439, p < 0.01). Intercorrelations also showed birth
weight had a moderate negative association with length of time on BCPAP (r = -0.306, p
< 0.01). CONCLUSIONS: The neonate was less likely to receive surfactant if, their
gestational age was older at birth, they had a heavier birth weight, and their length of time
on BCPCP was shorter. The data also demonstrated that the older the neonate’s
gestational age at birth and the heavier the neonatal birth weight equated to a shorter
length of time on BCPAP. Lastly the data demonstrated that the heavier the neonate’s
birth weight, the shorter length of time on BCPAP.
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CHAPTER I
Introduction
Oxygen therapy is often used to treat or relieve the effects of respiratory distress
in patients who suffer from respiratory disorders. It also increases the oxygen supply to
the lungs and to the body tissues of a patient who may have respiratory problems.
Oxygenation may also be achieved through mechanical ventilation (Tecklin, 2007).
Mechanical ventilation is defined as the method used to mechanically assist or
replace spontaneous breathing in patients who have problems breathing on their own.
Mechanical ventilation was first discovered and utilized by Vesalius, who used a reed
inserted into the trachea of animals to describe the process (Tecklin, 2007). Modern
mechanical ventilation was, however, pioneered by George Poe through his
experimentation with oxygen cylinders and tubing connected to suffocated rats (1908).
During mechanical ventilation, a tube is inserted into the mouth or through the
nose, bypassing the vocal cords going directly into the trachea but not past the carina.
This endotracheal or nasotracheal tube is attached to a breathing circuit that is then
connected to a mechanical ventilator for positive pressure ventilation (PPV). During
PPV the mechanical ventilator delivers set tidal volumes or pressures at a set rate per
minute. This is achieved by setting the parameters of the mechanical ventilator in an
appropriate mode to fit each patient’s ventilatory needs.
There are many types of mechanical ventilator modes. Some of the most
commonly used modes are: controlled mechanical ventilation (CMV), assist control
(A/C), and synchronized intermittent mechanical ventilation (SIMV). Typically, when
patients are first placed on the ventilator, the CMV mode is used to allow the patient to

rest and get accustomed to the ventilator assuming all the responsibility of breathing for
the patient. The CMV mode delivers a set amount of breaths to the patient. A typical
disadvantage of the CMV mode, if not correctly set, finds the patient fighting against the
ventilator if he/she is not adequately sedated.
The A/C mode also delivers a set number of breaths, but the patient may trigger
additional identical breath if he/she feels the need. The A/C mode helps the patient feel
more comfortable and lessens fighting against the ventilator as in the CMV mode. One
disadvantage of the A/C mode is that it may lead to a respiratory alkalosis if the patient
begins to take too many additional breathes.
If respiratory alkalosis occurs, this is an indication to switch the patient to SIMV
mode of ventilation which is often used to wean the patient. In SIMV mode the patient
also receives a set number of breathes. However, the difference between A/C and SIMV
is that in A/C the additional breathes the patient triggers are all at the set volume or
pressure, which is much higher than the patient would spontaneously breathe. This
process may lead to too much carbon dioxide removal. In SIMV, the patient only
receives the set number of breaths. Any additional breaths they want to take are done so
spontaneously, so the patient does not get another identical breath as in AC mode. That
breath will often be accompanied by pressure support, but it allows the patient to assume
some of the work of breathing.
A person on AC, for example, will be set at 12 breaths per minute and each
breath whether part of the 12 or triggered by the patient is set to a tidal volume of 600
mL. This means, for each additional breath the patient takes, he/she still receives 600
2

mL. A patient in SIMV with the same set 12 breathes per minute and a 600 mL tidal
volume may take another breath, but the patient will not be guaranteed 600 mL in the
additional breaths; instead he/she may only get 400 mL or whatever his/her respiratory
muscles can handle. If the patient has week respiratory muscles (i.e. diaphragm) his/her
spontaneous breath will be lower than someone with stronger respiratory muscles.
Pressure support may be added to the spontaneous breaths to help the patient reach a
target tidal volume and not to overly exhaust his/her muscles.
The addition of pressure support in the SIMV mode helps the patient overcome
the resistance of the endotracheal tube, thereby decreasing the work of breathing, and
also allowing the patient to assume some degree of responsibility. Pressure support is
different from other modes in that it is used during spontaneous breathing only. Pressure
support is often instituted during mechanical ventilation to enhance spontaneous
breathing during SIMV or may be used alone to facilitate weaning from the ventilator.
Each of the previous approaches are then achieved by setting parameters on the ventilator
for each mode.
The parameters that can be applied to each mode are either volume control (VC)
or pressure control (PC). During VC there is a set volume the patient must receive
allowing the pressure it takes to get to that volume to vary. This can be dangerous when
the patient’s compliance decreases and the pressures go above a certain level. In these
circumstances it is generally good practice to switch over to PC. During pressure control,
a set pressure is delivered to the patient’s lungs, resulting in varying volume delivery.
This helps in patients with decreased lung compliance such as those with acute
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respiratory distress syndrome (ARDS) or infants with respiratory distress syndrome
(RDS). In these patients the low volumes help prevent barotraumas, an adverse effect of
controlled mechanical ventilation from dangerously high pressures. Each patient’s ideal
pressures and volumes must be taken into consideration.
There are still many considerations and discrepancies as to what the ideal volumes
and pressures are for each of the adult, pediatric, and neonatal populations. Adult and
pediatric patients are often ventilated at 8-10 ml/kg of ideal body weight. It is essential to
use ideal body weight since the size of the lungs does not change with an overweight or
underweight person. For example, if a patient’s ideal body weight is 70kg; he/she would
receive a set tidal volume (Vt) of 560-700ml per breath. A neonate may be ventilated
anywhere from 4-10ml/kg as there is much variability in ventilator settings in this
population driven by a number of considerations. How a neonate is ventilated depends
on the underlying pathology. Additional considerations for mechanically ventilated
neonates include barotraumas or volutraumas, particularly in patients with extremely
non-compliant or underdeveloped/hypoplastic lungs. It is important not to cause more
damage since this population goes through several developmental stages in utero and if
born prematurely, complete development has not occurred.
The stages of human lung development cause a number of factors to be
considered when treating or ventilating a neonate. Human lung development goes
through several stages including the pseudoglandular stage (5-17 weeks) where the
diaphragm, conduction airways, mucus glands and goblet cells, columnar and cuboidal
epithelia develop and the nasal cavity separates from the nasopharynx. The canalicular
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stage (16-26 weeks) where there is enlargement of the airways, circulation, and gas
exchange unit’s takes place. Meconium is present in the bowel in this stage as well as
breathing movements with elastic lung tissue develop. Type one and two pneumocytes
develop into immature surfactant and cuboidal and squamous epithelia continue to
develop. The saccular (24-36 weeks) and alveolar (36 weeks to 2 years) stages are where
primitive alveoli form and the fetal lungs take up approximately 2-3% of total weight.
Surfactant matures and capillaries grow closer to the alveoli. This is important since
surfactant lowers the surface tension in the alveoli allowing them to open more easily and
to stay open. The closer the capillaries, the better the oxygen exchange between the
alveoli and the bloodstream, thus improving oxygen delivery to the tissues. There are 2575 million alveoli at birth, and they continue to multiply to 800 million in early
adolescence (Whitaker, 2001). If any of these stages do not take place, severe
underdevelopment occurs. For example, a neonate born at 26 weeks gestation will not
have developed alveoli or mature surfactant.
Neonates that are born prematurely have underdeveloped lungs and lack sufficient
surfactant, which often leads to respiratory distress syndrome (RDS). RDS is the leading
cause of morbidity and mortality in this premature population where the incidence and
severity of RDS is inversely proportional to gestational age (Sinha et al., 2008). The
chief pathology is a deficiency of surfactant, which leads to higher surface tension at the
alveolar surface and interferes with normal exchange of respiratory gases. Due to this
pathology , a number of anatomical abnormalities may occur including, increased
alveolar-capillary membrane permeability and thickness, decreased lung compliance,
increased resistance, increased work of breathing, ventilation/perfusion mismatch, and
5

impaired gas exchange (Sinha and Donn, 2006). The symptoms include tachypnea,
grunting, nasal flaring, retractions, and an increased work of breathing, distinguished by
the use of accessory muscles.
If RDS is not treated, or if the neonate does not respond acceptably and needs
mechanical ventilation and oxygen therapy for extended periods, bronchopulmonary
dysplasia may occur. Bronchopulmonary dysplasia (BPD) is a complex pulmonary
disorder characterized by lung inflammation and injury leading to abnormal repair
mechanisms and arrested lung development or decreased alveolarization (Polin and
Sahni, 2002). Many times these neonates develop ventilator-induced lung injury,
frequently as a result of high pressures. BPD and chronic lung disease (CLD) often result
from mechanical ventilation and the need for extended oxygen therapy greater than 28-30
days. Thirty to forty percent develop one of these disorders, sometimes severe enough to
interfere with normal growth and development (Sinha and Donn, 2006).
Mechanical ventilation in neonates was first conducted in 1959. Since its
inception, it has been noted that infant mortality due to respiratory problems such as RDS
has been greatly reduced. However, the use of mechanical ventilation has been
discredited with being responsible (in part) for the development of morbidity in neonates,
in particular BPD (Tecklin, 2007). Van Marter et al. (2000) showed intubation and
mechanical ventilation to be the single most important predictor of BPD.
Since mechanical ventilation is thought to be the most important predictor of
BPD, other treatment avenues should be explored. Developed by Professor Colin
Sullivan in Royal Prince Alfred Hospital, Sydney (1971), the Continuous Positive
6

Airway Pressure (CPAP) system was specifically meant to treat sleep apnea. The goal of
CPAP is to prevent atelectasis and airway closure. CPAP may also help reduce
ventilator-induced injury and other morbidities, as well as decrease hospital stay (Polin
and Sahni, 2002). In neonates, it is sometimes used to treat apnea due to prematurity.
Initially, continuous positive airway pressure machines were developed to help treat
apnea in patients at home but are now used in many hospitals. More specifically CPAP is
used in intensive care and high dependency units as a form of respiratory ventilation that
increases functional residual capacity (Paoli, 2008).
Physiological beneficial effects of CPAP include the following: increased
functional residual capacity and transpulmonary pressure, decreased pulmonary vascular
resistance and intrapulmonary shunt, increased static compliance and PaO2, and
decreased work of breathing and splinting of airway opening. Physiological risks include
air leak syndromes such as pneumothorax, pneumomediastinum, or pulmonary interstitial
emphysema. High CPAP levels may decrease compliance, increase work of breathing,
decrease venous return and consequently cause a decrease in cardiac output. Urine
output and renal clearance could also be decreased due to reflex secretion of antidiuretic
hormone (ADH) and increased levels of aldosterone (Polin and Sahni 2002).
An ideal CPAP delivery system should include a patient-system that is easily and
rapidly applicable, readily removable, re-connectable, non-traumatic, capable of
producing stable pressures at the desired levels, has the capacity to be connected to
humidification and supplementary oxygen systems, has low resistance to breathing,
minimal dead space, easily understood and maintained, readily sterilizable, safe, and cost
effective (Polin and Sahni, 2002). There are several types of CPAP systems, including
7

those that are ventilator-derived. In ventilator initiated CPAP, an infant flow driver is
utilized where gas flows into the CPAP device directly, as a result, changing the pressure.
Underwater bubble CPAP is where a tube is placed underwater to create a back-pressure
and oscillatory effect in the lungs. Several different methods are used to deliver CPAP
with various advantages and disadvantages. The most commonly used methods are the
endotracheal tube, nasal prongs (one or two), nasopharyngeal tube (one or two), mask, or
head box. Appropriately fitting nasal prongs are the most common method of CPAP
delivery.
Underwater bubble CPAP (BCPAP) is emerging as one of the safest ways to
employ CPAP. During bubble CPAP, the expiratory limb of the CPAP circuit vents
through an underwater seal resulting in bubbles that create pressure oscillations similar to
those produced by high-frequency ventilation. These vibrations are then transmitted back
to the airway opening (Pillow, 2007). BCPAP has a strong advantage in that it is
relatively simple and inexpensive. Another advantage is that if there is inadequate
pressure owing to a large leak, the bubbling will stop (Paoli, Morley, and Davis 2003).
Avery et al. (1987) found a significantly lower incidence of BPD at Columbia
University compared to other American centers, because they use CPAP, thus avoiding
intubation. Studies by De Klerk and De Klerk (2001) show that animal and neonates who
receive early nasal continuous positive airway pressure (NCPAP) have shown promising
results in terms of reduction of lung injury, need for mechanical ventilation, and
incidence of BPD. However, Plumm et al. (2006) and Lagercrantz (2007) have shown
that the use of NCPAP as an alternative mode of mechanical ventilation has similar risks
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in terms of development of BPD. These discrepancies may be due to staff knowledge of
CPAP implementation at each institution.
Purpose of the Study
The purpose of this study was to retrospectively investigate the length of stay on
bubble CPAP (BCPAP) considering gestational age, birth weight, and surfactant delivery
in the neonatal population born at an urban tertiary high load level three neonatal
intensive care unit. Bubble CPAP is often used as a means to avoid mechanical
ventilation, however, guidelines as to the most optimal variables are to predict length on
BCPAP have yet to be determined. The desired outcome of this study is to increase
awareness of these parameters and to aid in determining the ideal neonatal populations
that are successful with the implementation of BCPAP.
The following research questions were addressed to guide the acquisition of data
required to satisfy the requirements of the purpose/statement of the problem.
1. What was the neonate’s gestational age?
2. What was the neonate’s birth weight?
3. What was the neonate’s length of stay on bubble CPAP?
4. Does gestational age at birth have an effect on whether or not the neonate
receives surfactant?
5. Does birth weight have an effect on whether or not the neonate receives
surfactant?
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6. Does the length of time on BCPAP have an effect on whether or not the
neonate receives surfactant?
7. Does gestational age have an effect on length on bubble CPAP?
8. Does birth weight have an effect on length on bubble CPAP?
9. Does gestational age have an effect on birth weight?
Significance of study
This study is significant in that it may identify the types of neonates that are most
likely to have success on bubble CPAP. This study may also identify certain variables
that may be predictors of failure or success and optimize patient value. These results can
be generalized to the neonatal population who receive bubble CPAP at the institution
studied.
Definition of words and terms
Length of stay: The duration of stay at the same hospital from birth to discharge.
Length on BCPAP: The length of time the neonate is on BCPAP, whether continual
duration or split into different times.
Failure rates: If the neonate is put on bubble CPAP and must then be intubated and put
on mechanical ventilation, or death. Reasons to intubate and start mechanical
ventilation are often a PaCO2 ≥ 60 mmHg, a FiO2 ≥ 0.6 to maintain acceptable
oxygen saturation, and persistent serious apneic episodes.
Weight ranges:
Extremely low birth weight defined as less than 1000g at birth
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Very low birth weight defined as less than 1500g at birth
Low birth weight defined as less than 2500g at birth
Delimitations
This study includes a population of neonates between October 1, 2007 and April
1, 2009. The results of this study can only be generalized to this group of neonates.
Although these limiting factors are considered outside the control of the
researcher, it is important to recognize each one in order to effectively evaluate the
significance of this study. These limitations are not only present in the research setting,
but are also limiting factors in the clinical setting.
Assumptions
The intention of this study is to prove that the older the neonatal gestational age,
the shorter the time on BCPAP. This is assumed due to further development and lung
maturity of the lungs in this population. Heavier neonates may also have a shorter time
on BCPAP, because this type of neonate has more body fat and is usually farther along in
gestational age and maturity. Two neonates at the same gestational age but different
weights will have varying outcomes; where as the heavier neonate may have a shorter
duration on BCPAP compared to a smaller or lighter neonate. Two neonates that weigh
the same but have different gestational ages will have different outcomes in that the older
neonate will have shorter durations on BCPAP compared to the younger neonate at the
same weight due to lung maturity.
It is also assumed that neonates that were intubated and given surfactant will have
a lower surface tension leading to shorter durations on BCPAP. In these populations the
neonates are generally smaller and less mature, so the time on bubble CPAP may be just
11

as long as older and heavier neonates, however, the length of intervention may be longer
than the older or heavier neonate.
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CHAPTER II
Review of Literature
Continuous positive airway pressure (CPAP) is commonly used to prevent
intubation and mechanical ventilation. The beneficial effects of CPAP result from
splinting the airways, enhancing lung expansion, promoting increased residual lung
volume, preventing alveolar collapse, preserving endogenous surfactant, reducing
ventilation/perfusion mismatch, improving oxygenation, improving lung compliance,
reducing airway resistance, reducing the work of breathing, and stabilizing the respiratory
pattern (Morley, 1999).

At present, CPAP is commonly employed on patients with mild

to chronic respiratory failure. Its function has been effective in neonates early after birth.
For neonates with respiratory disorders, CPAP has been known to have an almost instant
effect in managing symptoms, sometimes symptoms are alleviated after a single days use.
If a response is not prompt, further use of CPAP may be required (Paoli, 2008).
Avery et al. (1987) conducted research to determine if there are differences
between medical centers regarding the occurrence of chronic lung disease due to
prematurity when birth weight, race, and sex are evaluated. Caucasian male infants with
birth weights between 700 and 1500 grams were used in the survey with the hypothesis
that chronic lung disease in these infants would be more common in certain institutions
than others. The results showed there was little discrepancy in survival rates between
centers, but there was a large difference in chronic lung disease at Columbia University.
This was possibly due to the institution of CPAP immediately after birth in all infants
showing respiratory distress instead of intubation. Researchers believe the use of CPAP
13

lessened injuries to the lungs of neonates such as barotraumas or volutraumas, which
often leads to further complications. Successes and positive outcomes were directly
related to the experiences of professional staff members in delivering this therapy
appropriately.
Pillow et al. (2007) evaluated differences in gas exchange and lung injury from
respiratory distress with either bubble CPAP (BCPAP) or constant pressure CPAP (CPCPAP) in intubated newborn, preterm lambs. Two groups in each category were
evaluated; one receiving the CPAP at 8 LPM and the other at 12 LPM, there was a total
of 4 groups. The authors hypothesized that in the newborn lung lacking surfactant, the
BCPAP would increase alveolar recruitment leading to increased volume compared to the
CP-CPAP. The results showed that BCPAP encouraged progressive arterial oxygen
levels and increased oxygen extraction which showed lower PaCO2 levels. Furthermore,
premature lung volumes were promptly stabilized at lower pressures used with BCPAP
while also reducing alveolar protein levels compared with CP-CPAP. Researchers
contemplated this may decrease the likelihood of chronic lung disease (CLD) or lung
injury but needs to be further examined. One limitation of this study was in using a
cuffed tracheal tube to deliver the CPAP instead of the usual nasal prong; however, they
still believe the findings were relevant.
In addition, Koyamaibole et al. (2005) studied all neonates admitted to the NICU
18 months before and 18 months after the implementation of bubble-CPAP use in that
hospital. The first period before bubble-CPAP use was from September 1, 2001 to May
14, 2003, while the second period after bubble-CPAP introduction was from May 15,
2003 to August 30, 2004. There were a total of 1,152 infants in the study. The
14

hypotheses were that bubble-CPAP would decrease the need for mechanical ventilation,
create fewer complications and be less costly. Bubble-CPAP produced a 50% reduction
in the need for mechanical ventilation; however, there was no change in mortality rate.
There were several limiting factors since this study was not a randomized trial;
nevertheless, the researchers noted that bubble-CPAP is an efficacious intervention that
should be implemented in developing countries due to the significant cost effectiveness.
This literature review will offer a subjective comparison of this mode of
mechanical ventilation, specifically continuous positive airway pressure, and more
specifically bubble CPAP in treating neonatal respiratory disorders. It will focus on
distinguishing gestational age, and weight differences among neonates. This review will
focus on outcomes such as length of stay, need for extended oxygen therapy such as
CPAP, and failure rates leading to intubation and mechanical ventilation.
Research studies dedicated to this review on neonates were limited due to the
rather sensitive nature of human bodies at this life stage, hence most of the literature as
referenced relates to a pediatric setting. Resources for the review were derived from
Public/Publisher MEDLINE (PubMed), CINHAL, Official Journal of the American
Academy of Pediatrics and independent sources and texts.
Continuous Positive Airway Pressure (CPAP)
Gestational age and weight differences
A study conducted by Plumm et al. (2001) indicated that there was no major
difference in the baseline characteristics of neonatal groups with respect to gestational
age and weight. About 6 % of neonates with birth weights below 1500 g who were
15

treated early with continuous positive airway pressure needed mechanical ventilation
within the first two hours of life.
Aly, Patel and El-Mohandes (2005) conducted a retrospective stratified cohort
study involving 234 very low birth weight (VLBW) preterm, hospital born neonates.
Results showed neonates who were briefly intubated and then extubated to CPAP were at
an increased risk for extended oxygen requirement, while those who failed CPAP were at
an increased risk for developing necrotizing enterocolitis.
Ammari et al. (2005) carried out a retrospective analysis of 261 neonates
weighing ≤ 1250 grams (VLBW) between June, 1999 , and July, 2002, to determine
which variables differentiate those who succeeded versus failed on CPAP, and whether it
can be predicted which neonates were likely to fail CPAP. Of the 229 neonates started
on CPAP, 174 (76%) were successful and 55 (24%) required intubation after 72 hours.
Only 32 (12%) were started on mechanical ventilation. Post menstrual age (PMA) and
neonate’s small for their gestational age (SGA) had significantly increased risk for CPAP
failure. Although, none had a positive predicted value above 55%, meaning they were
poor predictors of CPAP failure. Overall, successful neonates on CPAP were on average
3 gestational weeks older and weighed 300 grams more. The researchers agreed that part
of the difficulty in predicting failure was due to the difficulty in diagnosing severity of
RDS at birth.
Polin and Sahni (2002) compared CPAP delivery devices from several studies
and multiple different centers throughout the world while contrasting them to the original
Columbia University formative studies. The writers concluded neonates weighing more
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than 1000g had significant improvement using just CPAP while 75% of infants under
750g needed mechanical ventilation.
Morley et al. (2008) performed a randomized trial to test whether nasal CPAP was
superior to intubation and ventilation directly after birth in 610 preterm neonates of 25-28
gestational weeks of age. After 28 days, the results showed there was little variation in
the general mortality of the neonates. However, of the survivors, those on CPAP required
less need for oxygen and had fewer days of overall ventilation.
Sinha, Gupta, and Donn (2007) evaluated several different studies using CPAP,
intubation and mechanical ventilation, and surfactant. The authors stated the frequency
and severity of RDS was inversely proportional to the gestational age of the neonate.
Many were put on mechanical ventilation and of those, 30-40% developed chronic lung
disease (CLD). The authors noted that neonates born after 28 weeks did well on CPAP
and surfactant if needed, however those under 28 weeks required mechanical ventilation.
In addition, the authors felt early use of CPAP and surfactant may have a synergistic
effect when used together, because CPAP seems to conserve the existing surfactant. This
in turn reduces morbidities, with the exception of BPD.
BUBBLE CPAP
Gestational age and weight differences
Chan and Chan (2007) studied short term outcomes of 80 premature neonates
supported on CPAP with a birth weight of less than 1500g. Neonates born between
October, 2000, and March, 2002, (period 1) were compared to neonates born between
October, 2002, and March, 2004, (period 2). The neonates in period 1 were treated with
ventilator CPAP, while the neonates in period 2 were treated with bubble CPAP. The
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aim of the study was to evaluate respiratory outcomes with the hypothesis that bubble
CPAP would create less apnea post extubation and improved non-respiratory outcomes.
The results were separated into two birth weights of <1499g VLBW and <1000g
extremely low birth weight (ELBW). There was no increased incidence of
intraventricular hemorrhage (IVH) or CLD on BCPAP with less apnea as well, although
these neonates were on BCPAP longer than ventilator CPAP. There was also no increase
in non-respiratory morbidities with BCPAP, and 33% of the VLBW neonates were
successful with BCPAP alone. Most were initially intubated before receiving CPAP
which could have skewed results, so the scientists agreed a study with more samples
would be needed to determine long term effects.
Lee et al. (1998) performed a prospective randomized crossover study on ten
neonates weighing between 750-2000g at a gestational age between 28-34 weeks. The
neonates were diagnosed with wet lung or RDS and were put on either bubble CPAP or
ventilator-derived CPAP to determine differential outcomes. The hypothesis was that the
bubbles from the bubble CPAP would create vibrations similar to high-frequency
ventilation, thus improving gas exchange. The results showed all neonates on bubble
CPAP had a lower minute volume and respiratory rate when compared to ventilatorderived CPAP, although there was no difference in transcutaneous partial pressure of
CO2 (alveolar ventilation) or O2 saturation. It was suspected the decrease in the minute
volume and respiratory rate lead to a decreased work of breathing and fatigue for the
neonate to keep the same degree of gas exchange. However, the researchers were not
able to measure the tidal volumes, compliance or resistance accurately, thus, not allowing
for valid conclusions about the effects on the work of breathing.
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Narendran et al. (2003) compared the outcomes of all neonates between 401 and
1000g (ELBW) splitting them into two groups of which period 1 were historic controls
and period 2 neonates which were placed on bubble CPAP in the delivery room. The
researcher’s hypothesized that the early introduction of bubble CPAP would result in
improved respiratory outcomes. The hypotheses verified that days on mechanical
ventilation, delivery room intubations, and use of postnatal steroids were all significantly
decreased, while days on CPAP and weight of neonates after 36 weeks increased. There
was also no increase in complications and no neonate in period 2 developed a
pneumothorax. The researchers speculated that since CPAP is not invasive, there was a
much lower risk of infection which may contribute to the lower incidence of CLD.
Conclusion
Much research has been done on continuous positive airway pressure in helping
prevent intubation and mechanical ventilation. This has been mostly achieved by
increasing the neonates FRC, thus improving the work of breathing and oxygenation. It
is known that prevalence and severity of RDS was inversely proportional to the
gestational age, implying the lower the gestational age, the more severe the syndrome and
the more likely neonatal failure. Research also established that the lower the birth weight
and/or gestational age, the higher the failure rate and the longer the need for supplemental
therapies such as CPAP, surfactant delivery, oxygen therapy, and perhaps mechanical
ventilation. Research revealed that the earlier the initiation of CPAP the less likely the
neonate was to be intubated and mechanically ventilated, however this population was on
CPAP longer. When the neonate is put on CPAP instead of mechanical ventilation, there
is less potential for introduction of bacteria into the lungs; therefore those on CPAP had a
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lower incidence of infection. Research also suggests there is no increase in likelihood of
BPD or CLD, and in fact the rates might be decreased, although more research needed to
be conducted in this area. Lastly some research showed there was no difference in
mortality of neonates on CPAP versus those on mechanical ventilation, but of the
survivors, those on CPAP required supplemental therapies for shorter periods than those
on mechanical ventilation.
The introduction of continuous positive airway pressure in 1981 improved the
treatment of neonatal respiratory distress syndrome. CPAP is a less invasive technique
that if employed early has many beneficial outcomes. There are many types of CPAP
and different ways of producing the required pressure; however, bubble CPAP is a
valuable way of employing continuous positive airway pressure, because it is relatively
simple and inexpensive. Many hospitals can benefit from the use of BCPAP due to the
simplicity and ease of training personnel to correctly apply it. Hospitals will also benefit
because it is cost effective, thereby benefiting the institution financially.
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CHAPTER III

Methodology
The study performed is a retrospective study using existing data from an urban
tertiary high load level three neonatal intensive care unit (NICU). The data will be used
to answer the preset research questions.
Population
The subjects used were neonates from an urban tertiary high load level three
neonatal intensive care unit between October 5, 2007, and March 28, 2009. The patients
for this study will be a cross section of different weights and ages that will be utilized to
compute statistics and answer preset research question. Data was collected from 1256
patient’s charts from the above dates and 180 met the inclusion criterion. The inclusion
criterions were as follows: Neonates born at the hospital where research was being
conducted and placement on bubble CPAP at some point in time during their stay at that
hospital. Neonates that were excluded were those that left the hospital for surgeries and
then returned and those that were intubated and mechanically ventilated.
Instrumentation
The researcher performed all data collection for this project. The
researcher collected the data from computer charts at the urban tertiary high load level
three NICU. Data was collected as part of documentation files in the computerized
charting database utilized by the hospital and all identifiable markers were removed.
Approval was granted by the Institutional Review Board and a data agreement was
received from the hospital where research was done.
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The researcher met with the major professor and discussed what they wanted to
look at based on past research. All possible variables were discussed and critiqued. Each
was listed as a final product in Appendix A. Variables used included birth weight,
gestational age, actual age at time of intervention, surfactant use, and length of time on
BCPAP. It was assumed that surfactant use meant the neonate was first intubated to
instill the treatment. An instrument was developed to collect information from the
computerized charting database where as the medical record number was replaced with a
code that could not be traced back to any specific individual. The research instrument
included the following variables: birth weight, actual weight at time of intervention,
gestational age, actual age at time of intervention, surfactant use, and mechanical
ventilation use.
Once the instrument was developed, it was checked for variability by a major
professor in the Respiratory Care Program. To ensure reliability of measure, the
instrument was used on a selected group of patients. This patient group was checked
again by the director of the Respiratory Care Department at the urban tertiary high load
level three NICU to make sure that what was recorded on each instrument matched that
in the patient files. After the researcher met with the director, he ran a formula to gather
the data in the computerized charting database to extract the information for 25% of the
data, make sure it would be reliable, and answer what we wanted. Once we were able to
do that, 18 months of this data were run. A report was generated from Puritan Bennett’s
Clinivision mobile patient charting software, identifiable markers were blacked-out for
the researcher, and a copy was kept at the urban tertiary high load level three NICU. The
patients were selected by chart review from April 1, 2009, backwards to October 1, 2007.
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There were a total of 1,256 patients used, and 180 were included in this study. Inclusion
criterion was specifically bubble CPAP where the patient was placed on bubble CPAP at
some point in time during his/her stay in the NICU. Exclusion criterion included those
that were intubated and mechanically ventilated, those that were not born at that hospital,
and those that were transported out for surgeries and perhaps later returned. The patient’s
variables were recorded and placed into the instrument for further evaluation and
analysis.

Data Analysis
All statistical analyses were run using SPSS 16.0 statistical software. Descriptive
statistics were calculated for each variable. The magnitude of correlations between
variables was interpreted using the Davis conventions (Davis, 1971).

Coefficient
.70 or higher
.50 to .69
.30 to .49
.10 to .29
.01 to .09

Description
Very strong association
Substantial association
Moderate association
Low association
Negligible association

Person Product Moment correlation coefficients were calculated for all ratio data.
Eta correlation coefficients were used for calculations made between ratio and nominal
data. There data were placed into the tables by a brief narrative.

23

CHAPTER IV

Results
The purpose of this study was to retrospectively investigate the length of stay on
bubble CPAP (BCPAP) considering gestational age, birth weight, and surfactant delivery
in the neonatal population born at an urban tertiary high load level three neonatal
intensive care unit between October 1, 2007, and April 1, 2009. This research study
explored correlations between each variable to increase awareness of these parameters
and to aid in determining the ideal neonatal populations that are successful with the
implementation of BCPAP.
Descriptive Data
Gestational age at birth, birth weight, and length of time on BCPAP data was
presented in Table 1. One hundred eighty neonatal charts were included in this study.
The mean gestational age of these neonates was 32.263 weeks at birth, with a standard
deviation of 2.978. The mean birth weight of these neonates was 1.899 kg with a
standard deviation of 0.728. The mean length of time on BCPAP of 124.43 hours with a
standard deviation of 185.474 hours showing large variances in length of time in this
study.
Table I. Gestational age at birth, birth weight, and length of time on BCPAP
(n=180)
Minimum
Maximum
Mean
Std. Deviation
Gestational age at
birth (weeks)

25.714

40.000

32.263

2.978

Birth weight (kg)

.670

4.340

1.899

.728
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Length of time on
BCPAP (hours)

2

1018

124.430

185.474

Correlations
Intercorrelations were presented in table II. According to the Davis conventions,
gestational age at birth had a very strong positive association with birth weight (r = 0.811,
p < 0.01) and a moderate negative association with length of time on BCPAP (r = -0.439,

Table II. Intercorrelations (n = 180)

Gestational age at
birth

Gestational
age at birth

Birth
weight

Length of time on
BCPAP

1

.811**

-.439**

.000

.000

1

-.306**

Pearson
Correlation
Sig. (2-tailed)

Birth weight

Pearson
Correlation
Sig. (2-tailed)

Length of time on
BCPAP

Pearson
Correlation
Sig. (2-tailed)

.811**
.000

.000

-.439**

-.306**

.000

.000
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Note: All coefficients were Pearson product-moment
correlations.
**. Correlation was significant at the 0.01 level (2-tailed).

p < 0.01). The older the neonate’s gestational age at birth, the heavier the neonatal birth
weight. The older the neonate’s gestational age at birth the shorter the length of time on
BCPAP. Using the Davis conventions, birth weight had a moderate negative association
with length of time on BCPAP (r = -0.306, p < 0.01), meaning the heavier the neonate’s
birth weight, the shorter length of time on BCPAP.

According to the Davis conventions, there was a substantial association (reta =
0.562) between the gestational age at birth and surfactant delivery. As indicated, the
further along or older the gestational age at birth, the less likely that neonate was to
receive surfactant delivery.
According to the Davis conventions, there was a very strong association (reta =
1.000) between the birth weight and surfactant delivery. As indicated, the heavier the
neonate at birth, the less likely that neonate was to receive surfactant delivery.
According to the Davis conventions, there was a very strong association (reta =
0.914) between the length of time the neonate was on BCPAP and surfactant delivery.
As indicated, the shorter the duration on BCPAP, the less likely that neonate was to
receive surfactant delivery.
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CHAPTER V
Discussion
Respiratory distress syndrome (RDS) is the leading cause of morbidity and
mortality in the premature neonatal population. Therefore it is crucial to find the most
effective and efficient techniques to treat this population suffering from RDS and other
forms of respiratory distress. Bubble CPAP has often been employed as a safe, efficient
and effective way of applying non-invasive ventilation. It is used to avoid the need for
intubation and mechanical ventilation thereby reducing lung injury and other morbidities
as well as decreasing hospital stays.
The focus of this study was to investigate the length of stay on bubble CPAP
(BCPAP) considering gestational age, birth weight, and surfactant delivery in the
neonatal population. The mean neonatal gestational age was slightly over 32 weeks.
This demonstrated that the population of neonates that were most often put on BCPAP
were premature, however, not extremely premature. This indicated that the younger
gestational age neonates either failed BCPAP or were not even candidates and had to be
intubated and mechanically ventilated directly or soon after birth. This also indicated that
the term neonates have little to no problem with respiratory distress and may simply
require oxygen therapy without positive pressure. The mean birth weight was just shy of
2 kg indicating smaller neonates benefited from BCPAP without being considered very
low or extremely low birth weight. Those neonates had little if any fat on their body and
were generally less developed internally, meaning they needed more advanced
interventions than BCPAP. The mean length of time on BCPAP was about 125 hours or
5 days. This indicated the neonate needed several days to recruit enough alveoli to keep

his/her oxygenation levels satisfactory before being well enough to wean off. The
standard deviation was large however signifying some neonates responded right away,
while others took much longer, maybe even weeks.
Determination of surfactant delivery was evaluated by looking at several different
variables and how each affected whether or not the neonate received this therapy.
Interestingly, only about 10% of the neonates in this study received surfactant. This
indicates BCPAP as being a possible alternative method of increasing the neonatal
oxygenation status therefore decreasing respiratory distress. Since BCPAP increases
FRC, surfactant may not always be necessary if successful on BCPAP, however if the
response is questionable, surfactant may then be considered. The results displayed that
the older the gestational age at birth, the less likely the neonate was to receive surfactant
delivery. This was most likely due to a more maturely developed neonate which means
that neonate had the time in utero to develop enough natural surfactant. The results also
demonstrated that the heavier the neonate, the less likely he/she was to receive surfactant
delivery. This was most likely due to the neonate being older therefore having more
natural surfactant in his/her body. They also show that the shorter length of time spent on
BCPAP, the less likely that neonate was to receive surfactant delivery. It can be assumed
that the neonates that appear to be failing BCPAP may receive the surfactant delivery as
another attempt to keep him/her off the mechanical ventilator. Neonates that only spend
a short time on the BCPAP would probably not get surfactant delivery, because they may
respond positively to the BCPAP alone and not need further intervention.
Length of time on BCPAP was evaluated by looking at numerous different
variables and how each one influenced the time on BCPAP. The data showed that the
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older the neonate’s gestational age at birth, the heavier the neonatal birth weight and the
shorter length of time on BCPAP. This is most likely due to neonatal development. It is
indicated that since the neonate was further along in development, he/she should require
less intervention. The older the gestational age at birth, the more natural surfactant the
neonate should have which should lead to a larger FRC and the easier it should be for the
neonate to keep satisfactory oxygenation levels leading to less respiratory distress. Lastly
the data demonstrated that the heavier the neonate’s birth weight, the shorter length of
time on BCPAP which can also be due to a further developed neonate with more natural
surfactant and the likelihood of respiratory distress to be smaller.
While this study showed heavier and older neonates spent less time on BCPAP,
several other studies found contradicting evidence. Plumm et al. (2001) indicated that
there was no major difference in the baseline characteristics of neonatal groups with
respect to gestational age and weight while Ammari et al. (2005) showed successful
neonates on CPAP were on average 3 gestational weeks older and weighed 300 grams
more. Polin and Sahni (2002) concluded neonates weighing more than 1000g showed
significant improvement using just CPAP while 75% of infants under 750g needed
mechanical ventilation.
Bubble CPAP is commonly employed directly or soon after birth and might or
might not have an instant effect in terms of improvement. This may be due to varying
apparatus’s and interfaces used at each institution, or due to the training of the staff in the
use of BCPAP. Avery et al. (1987) found successes and positive outcomes were directly
related to the experiences of professional staff members in delivering this therapy
appropriately. Positive outcomes could be hindered if the staff doesn’t properly fit the
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interface to the neonates face, or if the most beneficial amount of pressure is not utilized
on each neonate. Staff at the hospital where this study was conducted were trained
extensively about the use of their BCPAP and how to determine success and failure or if
adjustments were needed.
This study was done at a hospital where the only form of non-invasive CPAP is
BCPAP. This could be due to the studies showing BCPAP to be more beneficial than
other forms of CPAP as well as more cost effective. Pillow et al. (2007) evaluated
differences in gas exchange and lung injury from respiratory distress with either bubble
CPAP (BCPAP) or constant pressure CPAP (CP-CPAP) in intubated newborn, preterm
lambs. The results showed that BCPAP encouraged progressive arterial oxygen levels
and increased oxygen extraction which showed lower PaCO2 levels. Furthermore,
premature lung volumes were promptly stabilized at lower pressures used with BCPAP
while also reducing alveolar protein levels compared with CP-CPAP. In addition,
Koyamaibole et al. (2005) studied all neonates admitted to the NICU 18 months before
and 18 months after the implementation of bubble-CPAP use in that hospital and results
showed BCPAP produced a 50% reduction in the need for mechanical ventilation.
There have been several studies comparing ventilator-derived CPAP and BCPAP
although, most of them compared specific weight classes or gestational age ranges. Chan
and Chan (2007) showed there was no increase incidence of intraventricular hemorrhage
(IVH) or CLD on BCPAP with less apnea as well. There was also no increase in nonrespiratory morbidities with BCPAP, and many neonates were successful with BCPAP
alone. Lee et al. (1998) showed all neonates on bubble CPAP had a lower minute volume
and respiratory rate when compared to ventilator-derived CPAP. Narendran et al. (2003)
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showed that the early introduction of bubble CPAP resulted in improved respiratory
outcomes. Perhaps all of these were due to the non-invasiveness of BCPAP, and the
pressure fluctuations allowed by the BCPAP helped decrease the work of breathing in
each neonate therefore leading to fewer incidences of CLD and BPD.
Significant limitations were considered in this current study. Neonates born of
different race as well as different genetic make-up might have affected the outcome of
this study. Socioeconomic status and access to prenatal care or lack thereof might have
affected the care the neonate received before birth. A mother’s well being, such as low
BMI, maternal/gestational diabetes, or other complications the mother was experiencing
might also have affected how the neonate responded to extra-uterine life. Lastly,
neonates that failed CPAP or had to be mechanically ventilated as well as those that had
surgery were excluded which might have skewed results.
Recommendations for future research
Future research in the area of non-invasive ventilation in the neonatal population
should be conducted. Forms of non-invasive ventilation such as BCPAP are very costeffective and the potential for introducing harmful bacteria into the lungs from intubation
is reduced greatly. A controlled, randomized in vivo study should be conducted on all
weights and gestational ages taking into account several variables. Variables that should
be looked at are: how surfactant or aerosol treatments affect the response to BCPAP, how
different ethnicities and genders respond to BCPAP could be beneficial in determining if
some are more likely to fail to succeed, and how the neonates of mothers with various
health problems such as pregnancy induced hypertension or diabetes respond to BCPAP
may be useful to look at too.
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BCPAP has several different interfaces that can be applied to the neonate.
Evaluation of how each interface affects pressures, oxygen carbon dioxide levels, and
work of breathing could be valuable for each institution in determining the most effective
device. Lastly, different brands of BCPAP should be evaluated to determine which is
readily and easily understood and applied by the practitioner as well as most efficient,
and effective.
Conclusion
Current studies on BCPAP are limited and this study along with others should
improve the respiratory care in the neonatal population. This study should bring
awareness to the need of more research on non-invasive ventilation and the variables
affecting outcomes. According to this study, birth weight, gestational age at birth, and
surfactant delivery all affect the length of time on BCPAP. It is hoped that further
research will be conducted in order to provide clinicians with the comprehensive
knowledge needed to provide neonatal patients suffering from respiratory distress with
care that is safe and effective.
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Appendix A

INSTRUMENTATION

Code: _______________________

Gestational age at birth: ______________________________

Weight at birth: _____________________________________

Length of time on BCPAP: ___________________________

Given surfactant?
Yes
No
 It is assumed the neonate was intubated to receive this treatment
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